Conmed Corp.
CNMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.48B
Close$
$127.59
159.1% upside
Current Fair Value
159.1% upsideUndervalued by 159.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.48 Billion |
|---|---|
| Enterprise Value | $2.27 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.52 |
| Beta | 0.94 |
| Outstanding Shares | 30,069,000 |
Return
| Return on Equity | 5.43% |
|---|---|
| Return on Assets | 2.46% |
| Return on Invested Capital | 6.26% |
Valuation & Multiples
| P/E Ratio | 26.59 |
|---|---|
| PEG | 345.17 |
| Price to Sales | 1.09 |
| Price to Book Ratio | 1.45 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | 19.67 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$1.11
Average shareholder expectationRevenue Estimate
$337.60 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$1.00
Average shareholder expectationRevenue Estimate
$336.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.45%▼ 112.56% |
|---|---|
| Total Invested | $6.03M▼ 99.47% |
| Investors Holding | 22▼ 229.00% |
ESG Score
No data
About Conmed Corp.
CEO: Curt Hartman